Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline

Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline

  • May 8, 2026

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.

Leave A Comment

Fields (*) Mark are Required